Pharmaceutical companies cannot patent generic ketamine for depression, but Janssen, a subsidiary of Johnson & Johnson, patented esketamine, which it named Spravato. The cost of the two drugs ...

Recent randomized clinical trial was conducted to evaluate the efficacy of intraoperative esketamine in reducing postpartum ...

More information: Antonio Del Casale et al, Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression, JAMA Psychiatry (2025). DOI: 10.1001/jamapsychiatry.2025.0200 ...

“Treatment-resistant forms of major depression are common and have large ... and suicidal thoughts. Esketamine is also being reviewed by the EMA, which is looking to make a decision later ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Not only does it take time to get an accurate depression diagnosis, finding the right medication to treat depression can be a complicated, delicate process. Someone may have a serious medical ...

Therapy is powerful—and even more effective when paired with TMS or SPRAVATO® (esketamine ... (ERP), to help clients work through anxiety, depression, trauma, OCD, and more.